Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.22.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash $ 1,454,538 $ 1,486,972
Prepaid expenses 343,383 353,541
Total current assets 1,797,921 1,840,513
Other noncurrent assets 155,655 233,482
Investments held in Trust Account 237,055,861 236,903,949
TOTAL ASSETS 239,009,437 238,977,944
Current liabilities    
Accounts payable and accrued expenses 313,160 71,214
Accrued offering costs 1,098 1,098
Total current liabilities 314,258 72,312
Deferred underwriting fee payable 8,050,000 8,050,000
Warrant liabilities 6,356,666 10,189,334
TOTAL LIABILITIES 14,720,924 18,311,646
Commitments and contingencies (see Note 6)  
Class A ordinary shares subject to possible redemption, $0.0001 par value; 500,000,000 shares authorized; 23,000,000 shares at redemption value as of March 31, 2022 and December 31, 2021 237,055,861 236,903,949
Shareholders’ Deficit    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized, no shares issued and outstanding (excluding 23,000,000 shares subject to possible redemption)
Class B ordinary shares, each having a par or nominal value of approximately $0.00009; 53,333,345.5 shares authorized; 7,666,667 shares issued and outstanding 690 690
Accumulated deficit (12,768,038) (16,238,341)
Total Shareholders’ Deficit (12,767,348) (16,237,651)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT $ 239,009,437 $ 238,977,944